fortune gems gcash

NEW YORK (AP) — Having waited 63 years for an Ivy League football title, Columbia had to stand by for another 40 minutes. The Lions had beaten Cornell 17-9 but needed a Harvard loss against Yale to secure a share of first place on the season's final day. So Columbia players retreated to their locker room on a hill a few hundred feet from Wien Stadium to watch the game in Boston on TV as a few hundred fans remained and gazed at the gold-and-orange foliage of Inwood Hill Park glowing in Saturday's afternoon sun. When Yale recovered onside kick with seconds left to ensure a 34-29 Harvard defeat, players let out a scream and streamed back onto the field to celebrate, smoke cigars, lift a trophy and sing “Roar, Lion, Roar” with family and friends. Who would have thunk it? “You had the realization of, oh, I’m a champion, which is something that hasn’t been said here in a while,” co-captain CJ Brown said. Harvard dropped into a tie with Columbia and Dartmouth at 5-2, the first time three teams shared the title since 1982 — the conference doesn't use tiebreakers. “It was nerve-wracking, for sure, but definitely exciting because that's something that not a lot of people have experienced, especially here," running back Joey Giorgi said. There have been several top players at Columbia — Sid Luckman, Marty Domres, Marcellus Wiley among them — but the school is perhaps better known for owners such as the New England Patriots' Robert Kraft and former Cleveland Browns head Al Lerner. Columbia's only previous championship in 1961 also was shared with Harvard. That Lions team was coached by Buff Donelli, a former Pittsburgh Steelers and Cleveland Rams coach who scored for the Americans in soccer's 1934 World Cup. Columbia set a then Division I-AA record with 44 consecutive losses from 1983-88, a mark broken by Prairie View’s 80 in a row from 1989-98. Since 1971, the Lions’ only seasons with winning records until now were 1994, 1996, 2017, 2018, 2021 and 2022. Al Bagnoli, who won nine Ivy titles in 23 years at Penn, couldn't manage one at Columbia from 2015-22. He quit six weeks before the 2023 opener, citing health, and was replaced on an interim basis by Mark Fabish, his offensive coordinator. Jon Poppe, now 39, was hired last December after working as a Bagnoli assistant at Columbia from 2015-17 between stints at Harvard from 2011-14 and 2017-22, plus one season as a head coach at Division III Union College. He led the Lions to a 7-3 record overall, their most wins in a coach's first season since George F. Sanford's team went 9-3 in 1899. Poppe had wife Anna and 7-year-old daughter with him in the locker room watching the countdown to the title. “Sixty-three years of whatever into now,” he said. “Just seeing a lot of that history myself, personally. This is a hugely — a feeling of elation, seeing my dad on the field, a lot of emotional things with that.” Before a crowd of 4,224, quarterback Caleb Sanchez's 1-yard touchdown run put Columbia ahead in the second quarter. Giorgi's 1-yard TD run opened a 14-3 lead in the third and Hugo Merry added a 25-yard field goal in the fourth, overcoming three field goals by Alan Zhao. Giorgi rushed for 165 yards and finished his career with 2,112, second in school history. He and Brown missed what would have been their freshman season in 2020 because of the coronavirus pandemic. Given Columbia's athletic history — the most successful sport is fencing — it is not an obvious football destination. “I saw the dedication, whether it resulted in wins or losses,” Brown said. “I saw their dedication to the product that they put out on the field and also the athletic department, the facilities that we had here, the busses on schedule and stuff, I was like, OK, they care about their athletes. People here want to win and it doesn’t matter what’s happened in the past, it matters what we’re going to do now.” Poppe cited a mindset. “You get 10 opportunities, unlike other sports, it is a grind to play this sport and prepare the way we do just for 10,” he said. As the final whistle sounded in Boston, Brown noted an unusual initial reaction in the locker room. “It was like kind of awe when they recovered the kick,” he said. “It was a lot quieter than you would think it would be, but you could feel the joy and the elation.” They accomplished what more than six decades of their predecessors had failed to. As the players headed out, Poppe had a final word. “Day off tomorrow,” he said. Get poll alerts and updates on the AP Top 25 throughout the season. Sign up here . AP college football: https://apnews.com/hub/ap-top-25-college-football-poll and https://apnews.com/hub/college-footballfortune gems gcash 。

The recent rankings that place China at the top in four different categories further solidify the country's position as a global powerhouse in table tennis. With a winning tradition, a culture of excellence, and a deep pool of talent to draw from, Team China shows no signs of slowing down as they continue to dominate the world stage.Charles Schwab Investment Management Inc. Buys 502,999 Shares of Sealed Air Co. (NYSE:SEE)

Edgewise Therapeutics ( NASDAQ:EWTX – Free Report ) had its price target boosted by Truist Financial from $33.00 to $50.00 in a report issued on Wednesday morning, Benzinga reports. Truist Financial currently has a buy rating on the stock. Several other research firms have also commented on EWTX. Evercore ISI began coverage on shares of Edgewise Therapeutics in a research report on Friday, November 22nd. They issued an “outperform” rating and a $45.00 price target on the stock. Royal Bank of Canada reiterated an “outperform” rating and set a $32.00 target price on shares of Edgewise Therapeutics in a report on Tuesday, September 17th. Wedbush boosted their price target on Edgewise Therapeutics from $44.00 to $45.00 and gave the stock an “outperform” rating in a report on Friday, November 8th. JPMorgan Chase & Co. increased their price objective on Edgewise Therapeutics from $30.00 to $31.00 and gave the company an “overweight” rating in a research note on Monday, August 12th. Finally, Piper Sandler lifted their price objective on Edgewise Therapeutics from $48.00 to $51.00 and gave the stock an “overweight” rating in a research report on Friday, October 11th. Six research analysts have rated the stock with a buy rating, According to MarketBeat.com, the company presently has an average rating of “Buy” and an average target price of $42.33. View Our Latest Research Report on EWTX Edgewise Therapeutics Price Performance Edgewise Therapeutics ( NASDAQ:EWTX – Get Free Report ) last announced its quarterly earnings results on Thursday, November 7th. The company reported ($0.36) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.37) by $0.01. On average, research analysts expect that Edgewise Therapeutics will post -1.46 earnings per share for the current fiscal year. Insider Buying and Selling In related news, CMO Joanne M. Donovan sold 7,162 shares of Edgewise Therapeutics stock in a transaction on Friday, September 20th. The stock was sold at an average price of $28.29, for a total value of $202,612.98. Following the transaction, the chief marketing officer now owns 14,538 shares in the company, valued at approximately $411,280.02. This trade represents a 33.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website . Also, CFO R Michael Carruthers sold 125,092 shares of the business’s stock in a transaction dated Friday, September 20th. The shares were sold at an average price of $28.57, for a total value of $3,573,878.44. Following the sale, the chief financial officer now directly owns 6,904 shares of the company’s stock, valued at approximately $197,247.28. This trade represents a 94.77 % decrease in their position. The disclosure for this sale can be found here . Over the last ninety days, insiders have sold 278,176 shares of company stock worth $7,893,316. 24.11% of the stock is owned by company insiders. Institutional Trading of Edgewise Therapeutics Institutional investors have recently modified their holdings of the company. Quest Partners LLC raised its holdings in Edgewise Therapeutics by 156.9% in the second quarter. Quest Partners LLC now owns 1,742 shares of the company’s stock valued at $31,000 after buying an additional 1,064 shares during the period. Meeder Asset Management Inc. purchased a new position in shares of Edgewise Therapeutics in the 2nd quarter valued at $35,000. Mirae Asset Global Investments Co. Ltd. lifted its holdings in shares of Edgewise Therapeutics by 21.7% during the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 3,392 shares of the company’s stock valued at $88,000 after acquiring an additional 604 shares in the last quarter. Chicago Partners Investment Group LLC purchased a new stake in Edgewise Therapeutics during the 3rd quarter worth $161,000. Finally, Arizona State Retirement System acquired a new stake in Edgewise Therapeutics in the 2nd quarter valued at $188,000. About Edgewise Therapeutics ( Get Free Report ) Edgewise Therapeutics, Inc, a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of muscle disorders. Its lead product candidate, EDG-5506, an orally administered small molecule that is in Phase II clinical trials, designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy. Featured Stories Receive News & Ratings for Edgewise Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edgewise Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter .The milestone of selling 1.1 million copies on Steam and generating nearly $200 million in revenue is a testament to the hard work and dedication of the development team. Their passion for creating a game that resonates with players shines through in every aspect of Exile's Path 2, from its breathtaking visuals to its engaging gameplay. The success of the game not only reflects its quality but also highlights the enduring appeal of well-crafted, immersive gaming experiences that transport players to new and exciting worlds.